The Turkish Competition Authority re-examines allegations on exclusionary practises in the healthcare sector (Siemens)

Upon the Ankara 7 th Administrative Court’s annulment [1] its 2016 decision [2], the Competition Board (“Board”) re-examined the allegations against Siemens Healthcare Sağlık A.Ş. (“Siemens”) concerning abuse of dominance by way of excluding the competitors, engaging in discriminatory practices, and violating the obligations which had been stipulated in previous Board decisions against Siemens [3]. In conclusion, the Board found that Siemens did not abuse its dominant position in the markets for services and spare parts for the Siemens brand medical diagnostic and imaging devices; thus, did not violate Article 6 of Law No. 4054 on the Protection of Competition (“Law No. 4054”). Background The applicant, Siemed Tıbbi Sistemleri Elektrik Elektronik İletişim Sağlık Hizmetleri Danışmanlık

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • ELIG Gürkaynak Attorneys-at-Law (Istanbul)
  • ELIG Gürkaynak Attorneys-at-Law (Istanbul)
  • ELIG Gürkaynak Attorneys-at-Law (Istanbul)

Quotation

Gönenç Gürkaynak, Ceren Özkanlı Samlı, Sinem Ugur, The Turkish Competition Authority re-examines allegations on exclusionary practises in the healthcare sector (Siemens), 19 November 2020, e-Competitions November 2020, Art. N° 99879

Visites 63

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues